Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The most common skin issues in females with Polycystic Ovary Syndrome (PCOS) are excessive hair growth, hair loss, oily skin, acne, dark skin patches, and skin tags, which may be linked to hormone and insulin levels.

The document suggests new ways to assess and diagnose hyperandrogenism to improve accuracy.

A new treatment using special nanovesicles with linoleic acid shows promise in improving hair growth and reducing irritation for hair loss.

A new treatment using conjugated linoleic acid nanovesicles can rejuvenate hair follicles and improve hair growth in androgenic alopecia.

A new treatment using conjugated linoleic acid in nanovesicles can rejuvenate hair follicles and improve hair growth in androgenic alopecia.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

Male pattern baldness worsens with age and can be treated with medications like minoxidil and finasteride, but side effects and personalized care are important.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Melanoma patients can learn to check their skin, early balding in men may indicate similar risks as PCOS in women, certain criteria can help predict skin cancer behavior, small skin cancer may not need extra therapy after surgery, and sterile gloves don't reduce infection in minor surgeries.

Researchers identified genes in scalp hair follicles that may affect hair traits and hair loss.

ALRV5XR effectively promotes hair regrowth in both men and women through different mechanisms.

AMP-303 injections can increase hair growth in androgenetic alopecia with minimal side effects.

Men with early hair loss and hormonal changes like PCOS could be the male equivalent of PCOS, not linked to metabolic syndrome.

Lifestyle choices like stress, smoking, heavy drinking, sun exposure, and chemical hair treatments might speed up hair loss in people with androgenetic alopecia.

Conventional treatments like dutasteride and minoxidil are effective for male hair loss, with some alternative treatments also showing promise.

The conclusion is that a treatment called cp-asiAR can reduce hair loss and promote hair growth, making it a potential new therapy for androgenetic alopecia.

Ovarian Hyperthecosis caused hypersexuality in an older woman and was successfully treated with surgery.

cp-asiAR may effectively treat hair loss by targeting androgen receptors.

A genetic test can identify people at risk of male pattern baldness early, allowing for quicker treatment.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Mohamed Kandil suggests renaming Polycystic Ovary Syndrome to "Polyfollicular Anovulatory Androgenic Syndrome" to better describe its symptoms, but concerns exist that it may not cover all related issues like obesity and depression.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

PCOS is caused by both genetics and environmental factors like diet and obesity.

Androgen receptors are active in many tissues of both male and female mice, not just reproductive organs.

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

New treatments for male hypogonadism are effective and should be personalized.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

Hirsutism is a strong sign of high male hormones and metabolic problems in women with PCOS, but acne and hair loss are not.

The document suggests treating individuals with nonclassic congenital adrenal hyperplasia who show symptoms, especially those related to excess male hormones.